{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T08:53:52Z","timestamp":1775292832911,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Auton Res"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s10286-007-1002-2","type":"journal-article","created":{"date-parts":[[2008,3,26]],"date-time":"2008-03-26T08:54:39Z","timestamp":1206521679000},"page":"19-24","source":"Crossref","is-referenced-by-count":72,"title":["L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension"],"prefix":"10.1007","volume":"18","author":[{"given":"Horacio","family":"Kaufmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,27]]},"reference":[{"key":"1002_CR1","first-page":"523","volume":"193","author":"J Bartholini","year":"1975","unstructured":"Bartholini J, Constantinidis J, Puig M, Tissot R, Pletscher A (1975) The stereoisomers of 3,4-dihydroxyphenylserine as precursors of norepinephrine. J Pharmacol Exp Ther 193:523\u2013532","journal-title":"J Pharmacol Exp Ther"},{"key":"1002_CR2","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0140-6736(87)91317-1","volume":"2","author":"I Biaggioni","year":"1987","unstructured":"Biaggioni I, Robertson D (1987) Endogenous restoration of noradrenaline by precursor therapy in dopamine-beta-hydroxylase deficiency. Lancet 2:1170\u20131172","journal-title":"Lancet"},{"key":"1002_CR3","first-page":"431","volume":"5","author":"H Blaschko","year":"1950","unstructured":"Blaschko H, Burn JH, Langemann H (1950) The formation of noradrenaline from dihydroxyphenylserine. Br J Pharmacol 5:431\u2013437","journal-title":"Br J Pharmacol"},{"key":"1002_CR4","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1212\/WNL.53.9.2151","volume":"53","author":"R Freeman","year":"1999","unstructured":"Freeman R, Landsberg L, Young J (1999) The treatment of neurogenic orthostatic hypotension with 3,4-dl-threo-dihydroxyphenylserine: a randomized, placebo-controlled, crossover trial. Neurology 53:2151\u20132157","journal-title":"Neurology"},{"key":"1002_CR5","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1212\/01.wnl.0000178980.83477.14","volume":"65","author":"CH Gibbons","year":"2005","unstructured":"Gibbons CH, Vernino SA, Kaufmann H, Freeman R (2005) l-DOPS therapy for refractory orthostatic hypotension in autoimmune autonomic neuropathy. Neurology 65:1104\u20131106","journal-title":"Neurology"},{"key":"1002_CR6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10286-004-0221-z","volume":"14","author":"DS Goldstein","year":"2004","unstructured":"Goldstein DS, Holmes C, Kaufmann H, Freeman R (2004) Clinical pharmacokinetics of the norepinephrine precursor l-threo-DOPS in primary chronic autonomic failure. Clin Auton Res 14:363\u2013368","journal-title":"Clin Auton Res"},{"key":"1002_CR7","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s004010050693","volume":"94","author":"K Hague","year":"1997","unstructured":"Hague K, Lento P, Morgello S, Caro S, Kaufmann H (1997) The distribution of Lewy bodies in pure autonomic failure: autopsy findings and review of the literature. Acta Neuropathol (Berl) 94:192\u2013196","journal-title":"Acta Neuropathol (Berl)"},{"key":"1002_CR8","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1254\/jjp.26.380","volume":"26","author":"C Inagaki","year":"1976","unstructured":"Inagaki C, Fujiwara H, Tanaka C (1976) Inhibitory effect of (+)threo-3,4-dihydroxy-phenylserine (DOPS) on decarboxylation of (\u2212)threo-dops. Jpn J Pharmacol 26:380\u2013382 Issn: 0021-5198","journal-title":"Jpn J Pharmacol"},{"key":"1002_CR9","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1212\/WNL.47.6.1370","volume":"47","author":"H Kaufmann","year":"1996","unstructured":"Kaufmann H (1996) Could treatment with DOPS do for autonomic failure what DOPA did for Parkinson\u2019s disease? Neurology 47:1370\u20131371","journal-title":"Neurology"},{"key":"1002_CR10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF02260889","volume":"3","author":"H Kaufmann","year":"1991","unstructured":"Kaufmann H, Oribe E, Yahr MD (1991) Differential effect of l-threo-3,4-dihydroxyphenylserine in pure autonomic failure and multiple system atrophy with autonomic failure. J Neural Transm Park Dis Dement Sect 3:143\u2013148","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"1002_CR11","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/01.CIR.0000083721.49847.D7","volume":"108","author":"H Kaufmann","year":"2003","unstructured":"Kaufmann H, Saadia D, Voustianiouk A, Goldstein DS, Holmes C, Yahr MD, Nardin R, Freeman R (2003) Norepinephrine precursor therapy in neurogenic orthostatic hypotension. Circulation 108:724\u2013728","journal-title":"Circulation"},{"key":"1002_CR12","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S0140-6736(87)91318-3","volume":"2","author":"AJ Man in\u2019t Veld","year":"1987","unstructured":"Man in\u2019t Veld AJ, Boomsma F, van den Meiracker AH, Schalekamp MA (1987) Effect of unnatural noradrenaline precurser on sympathetic control and orthostatic hypotension in dopamine-beta-hydroxylase defficiency. Lancet 2:1172\u20131175","journal-title":"Lancet"},{"key":"1002_CR13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF02298955","volume":"11","author":"CJ Mathias","year":"2001","unstructured":"Mathias CJ, Senard JM, Braune S, Watson L, Aragishi A, Keeling JE, Taylor MD (2001) l-threo-dihydroxyphenylserine (l-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure. Clin Auton Res 11:235\u2013242","journal-title":"Clin Auton Res"},{"key":"1002_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.31.1.1","volume":"31","author":"RJ Polinsky","year":"1981","unstructured":"Polinsky RJ, Kopin IJ, Ebert MH, Weise V (1981) Pharmacologic distinction of different orthostatic hypotension syndromes. Neurology 31:1\u20137","journal-title":"Neurology"},{"key":"1002_CR15","first-page":"127","volume":"6","author":"CG Schmiterlow","year":"1951","unstructured":"Schmiterlow CG (1951) The formation in vivo of noradrenaline from 3:4-dihydroxyphenylserine (noradrenaline carboxylic acid). Br J Pharmacol 6:127\u2013134","journal-title":"Br J Pharmacol"},{"key":"1002_CR16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/BF00570160","volume":"17","author":"T Suzuki","year":"1980","unstructured":"Suzuki T, Higa S, Tsuge I, Sakoda S, Hayashi A, Yamamura Y, Takaba Y, Nakajima A (1980) Effect of infused l-threo-3,4-dihydroxyphenylserine on adrenergic activity in patients with familial amyloid polyneuropathy. Eur J Clin Pharmacol 17:429\u2013435","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Clinical Autonomic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-007-1002-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10286-007-1002-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-007-1002-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:12:37Z","timestamp":1559117557000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10286-007-1002-2"}},"subtitle":["The US experience"],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":16,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["1002"],"URL":"https:\/\/doi.org\/10.1007\/s10286-007-1002-2","relation":{},"ISSN":["0959-9851","1619-1560"],"issn-type":[{"value":"0959-9851","type":"print"},{"value":"1619-1560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}